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Identity 
Other names: CSX; CSX1; NKX2E; Hs.54473; 
NM_004387; cardiac-specific homeobox 
HGNC (Hugo): NKX2-5 
Location: 5q35.2 
Local order: cen--- BNIP1---NKX2-5--- STC2---tel. 
DNA/RNA 
Description 
The gene has two exons and one intron. 
Transcription 
Transcription takes place in a telomere --> centromere 
orientation. The length of the processed mRNA is 






324 amino acids; 35-38 kDa, depending on 
phosphorylation status; contains one TN domain 
(residues 10-21), one homeodomain (residues 138-
197), and one NK2 domain (residues 212-234). 
Expression 
Expression is mainly restricted to the heart. But during 
embryogenesis NKX2-5 expression has also been 
detected in spleen-precursor cells. 
Localisation 
Cytoplasmatic and nuclear, probably depending on 
phosphorylation status. 
 
The gene for NKX2-5 comprizes two exons of 510 and 1075 bp, respectively. The length of the intron is 1540 bp. Positions of start and 
stop codons are indicated. These data refer to ENSEMBL transcript. 
 










Figure shows mutations causing various cardiac anomalies. NKX2-5 contains two exons encoding a 324-amino acid protein including a 
tinman domain (TN), homeodomain (black) and an NK2 domain. Truncation mutations are shown above, missense mutations below. ∆ 
indicates deletion of the intron 1 splice donor site. Note clustering of mutations within the homeobox itself. 
 
Function 
Involved in differentiation processes in heart 
development and in homeostasis and survival of 
cardiac myocytes. 
Homology 




Among vertebrates, NKX2-5 is the most highly 
conserved of the Drosophila tinman homologs and 
subject to transcriptional control via complex series of 
cis-regulatory elements both proximal and distal of the 
transcription unit. 
Germinal 
Haploinsufficiency due to loss-of-function mutations is 
associated with atrioventricular conduction defects and 
tetralogy of Fallot. 
Somatic 
Recently identified in cardiac disease. 
Implicated in 
t(5;14)(q35;q32) in acute lymphoblastic 
leukaemia (ALL) and t(5;14)(q35;q11) in 
chronic lymphocytic leukaemia 
Note 
NKX2-5 lies circa 2 Mbp telomeric of TLX3 which is 
recurrently targeted for juxtaposition with BCL11B by 
t(5;14)(q35;q32) in a subset of patients (both pediatric 
and adult) in T-cell ALL. Studies performed on 
pediatric T-ALL cell lines have shown that visually 
identical t(5;14) rearrangements may target NKX2-5 or 
TLX3 . Initial data suggest that the t(5;14) variant 
targeting NKX2-5 is clinically rare. The clinical 
involvement t(5;14)/NKX2-5 has only been recently 
identified but has yet to be published. In addition to T-
ALL, NKX2-5 rearrangement has been reported in a 
case of chronic lymphocytic leukaemia (CLL) with 





The t(5;14) rearrangements respectively targeting 
NKX2-5 and TLX3 which lies about 2Mbp centromeric 
are cytogenetically indistinguishable in both 
conventionally banded and chromosome painting 
preparations. In addition, both sets of rearrangements 
are cryptic as equal and similarly banded material from 
chromosomes 5 and 14 are exchanged. Thus, analysis 
using sets of BAC clones covering both TLX3 and 





Figure shows FISH analysis of t(5;14) in the pediatric T-ALL cell 
line PEER using three RP11 library clones located immediately 
centromeric (779o18, labelled red), spanning (466h21, green) 
and telomeric (45g21, yellow) of NKX2-5. (See below for map.) 
The rearrangement may be a simple insertion or, a double 
translocation whereby chromosome 14 material is first 
translocated onto the der(5) and then returned by a non-
reciprocal copying process to the der(14) accompanied by 
genomic material surrounding NKX2-5. 












NKX2-5 is developmentally silenced in thymocytes. 
Formation of t(5;14) juxtaposes NKX2-5 with enhancer 
elements probably cognate with T-cell specific DNaseI 
hypersensitive sites present in the downstream 
regulatory region of BCL11B which plays a central role 
in thymic maturation. It is believed that both TLX3 and 
NKX2-5 are reactivated by similar mechanisms 
involving juxtaposition with T-cell specific regulatory 
regions. Structural similarities shared by NKX2-5, 
TLX1 and TLX3 add weight to this hypothesis. 
Breakpoints 
 
Figure shows breakpoints described in ALL cell lines with t(5;14)(q35.2;q32) which juxtaposes NKX2-5 with the downstream region of 
BCL11B - outer breakpoints; and in a case of CLL with t(5;14)(q35.2;q11) where the activating locus was TRD - middle breakpoint. 
Completion of sequencing data at the NKX2-5 locus has repositioned some of the BAC clones, allowing further refinement of the 
breakpoint assignments. It is now clear that known breakpoints tightly flank NKX2-5 without disrupting the transcription unit itself. Thus, 
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